Position in SLDB
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$1,049,629
+$458,488 QoQ
Shares Held
105,068
+28.0% QoQ
Ownership
0.098%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#58
of 155 holders
Holding Since
Mar 2020
22 quarters on record
Voting authority
Sole 24%
Shared 0%
None 76%
Common Shares in SLDB Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026RHUMBLINE ADVISERS holds $1,404,724,682 across 329 Biotechnology names. SLDB ranks #132 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
396,380 | $196,893,837 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
157,794 | $98,390,870 | |
| 3 | MRNA |
Moderna, Inc.
|
809,853 | $56,714,005 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
165,579 | $49,844,246 | |
| 5 | INCY |
Incyte Corp
|
428,533 | $48,578,500 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
226,008 | $42,326,778 | |
| 7 | ROIV |
Roivant Sciences Ltd.
|
1,178,789 | $41,717,342 | |
| 8 | JAZZ |
Jazz Pharmaceuticals plc
|
163,018 | $39,282,447 |
All Filings in SLDB
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,049,629 | 105,068 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $591,141 | 82,103 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $465,706 | 82,572 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $581,713 | 94,281 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $497,563 | 102,169 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $145,861 | 39,422 | Shares | Sole | 2025-05-29 | |
| 2024-12-31 | $174,708 | 43,677 | Shares | Sole | 2025-05-29 | |
| 2024-09-30 | $275,426 | 39,516 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $191,492 | 33,773 | Shares | Sole | 2024-08-01 | |
| 2024-03-31 | $13 | 0 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $6 | 0 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $2 | 0 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $141 | 27 | Shares | Sole | 2023-08-08 | |
| 2022-03-31 | $85,982 | 71,652 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $138,083 | 78,905 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $178,305 | 74,605 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $266,920 | 72,929 | Shares | Sole | 2021-08-05 | |
| 2021-03-31 | $193,859 | 35,056 | Shares | Sole | 2021-05-06 | |
| 2020-12-31 | $265,307 | 35,001 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $57,530 | 28,340 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $103,675 | 35,384 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $63,691 | 26,649 | Shares | Sole | 2020-05-06 | |
| No filing history on record for this holder in this stock. | ||||||